We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+24.68%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.51B
AUM Growth
+$758M
Cap. Flow
+$605M
Cap. Flow %
17.25%
Top 10 Hldgs %
47.4%
Holding
285
New
108
Increased
67
Reduced
35
Closed
69

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$28.2M
2
ALGN icon
Align Technology
ALGN
+$19.3M
3
APR
Apria, Inc. Common Stock
APR
+$17.3M
4
CUTR
Cutera, Inc.
CUTR
+$14.8M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$13M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$14.4M
2
AFIB
Acutus Medical Inc
AFIB
+$13.5M
3
SHC icon
Sotera Health
SHC
+$12.9M
4
OPCH icon
Option Care Health
OPCH
+$12.1M
5
BNGO icon
Bionano Genomics
BNGO
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33%
2 Industrials 1.49%
3 Materials 0.46%
4 Financials 0.45%
5 Consumer Staples 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHAT icon
151
Phathom Pharmaceuticals
PHAT
$742M
$2.4M 0.07%
63,772
+3,772
+6% +$158K
KRRO icon
152
PUT
Korro Bio
KRRO
$197M
$2.38M 0.07%
+5,000
New +$9.71M
PSTX
153
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$2.26M 0.06%
+236,311
New +$2.32M
VRTX icon
154
Vertex Pharmaceuticals
VRTX
$133B
$2.2M 0.06%
+10,243
New +$2.25M
MGNX icon
155
MacroGenics
MGNX
$256M
$2.19M 0.06%
+68,792
New +$1.67M
FVAM
156
DELISTED
5:01 Acquisition Corp
FVAM
$2.18M 0.06%
219,136
+1,136
+0.5% +$11.9K
GNLN icon
157
Greenlane Holdings
GNLN
$1.19M
– –
0
– –
ARVN icon
158
Arvinas
ARVN
$580M
$2.12M 0.06%
32,017
+2,017
+7% +$154K
AVDL
159
DELISTED
Avadel Pharmaceuticals
AVDL
$2.12M 0.06%
234,122
-155,449
-40% -$1.26M
PMGMU
160
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
$2.1M 0.06%
+211,472
New +$2.14M
BGMS
161
Bio Green Med Solution Inc
BGMS
$5.1M
$1.95M 0.06%
76
-56
-42% -$1.58M
NVTA
162
PUT
DELISTED
Invitae Corporation
NVTA
$1.91M 0.05%
+50,000
New +$2.27M
AFMD
163
DELISTED
Affimed
AFMD
$1.9M 0.05%
24,054
+14,054
+141% +$912K
INO icon
164
CALL
Inovio Pharmaceuticals
INO
$79.6M
$1.86M 0.05%
+16,667
New +$2.19M
LOGC
165
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$1.84M 0.05%
253,102
+3,102
+1% +$25.5K
AMWL icon
166
PUT
American Well
AMWL
$215M
$1.74M 0.05%
+5,000
New +$2.71M
ACHL
167
DELISTED
Achilles Therapeutics
ACHL
$1.71M 0.05%
+103,026
New +$1.71M
CGEN icon
168
CALL
Compugen
CGEN
$236M
$1.7M 0.05%
+198,400
New +$2.2M
VERO
169
DELISTED
Venus Concept
VERO
$1.65M 0.05%
+4,251
New +$1.69M
RPTX
170
DELISTED
Repare Therapeutics
RPTX
$1.65M 0.05%
+53,640
New +$1.82M
RCUS icon
171
CALL
Arcus Biosciences
RCUS
$3.69B
$1.6M 0.05%
+56,900
New +$1.98M
CTMX icon
172
CytomX Therapeutics
CTMX
$760M
$1.56M 0.04%
+202,478
New +$1.6M
RCOR
173
DELISTED
Renovacor, Inc.
RCOR
$1.55M 0.04%
+153,960
New +$1.59M
EXEL icon
174
Exelixis
EXEL
$12.5B
$1.5M 0.04%
+66,460
New +$1.5M
HIIIU
175
DELISTED
Hudson Executive Investment Corp. III Unit
HIIIU
$1.49M 0.04%
+150,000
New +$1.51M
5 6
7
8 9

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2021 Portfolio in Review

As of Q1 2021, Pura Vida Investments held 285 positions worth $3.51B, up 28% from $2.75B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments deployed $605M of net new capital in Q1 2021, opening 108 new positions and adding to 67 existing holdings. Its largest new stake was Align Technology: 35,000 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was Vericel Corp, an estimated $14.4M trimmed.

  • Pura Vida Investments's largest Q1 2021 buy was Align Technology: 35,000 shares worth $19M.
  • Pura Vida Investments added most to Insight Molecular Diagnostics in Q1 2021, an estimated $28.2M increase.
  • Pura Vida Investments's biggest Q1 2021 reduction was Vericel Corp, cutting an estimated $14.4M.
  • Pura Vida Investments fully exited Acutus Medical Inc in Q1 2021, selling an estimated $13.5M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $3.51B portfolio in Q1 2021.
  • Pura Vida Investments opened 108 new positions and closed 69 in Q1 2021.
  • Pura Vida Investments's portfolio value rose 28% quarter-over-quarter to $3.51B.

Based on Pura Vida Investments's 13F filing for Q1 2021, filed 12 May 2021.